Skip to contentClarengateINTELLIGENCE
Companies/10793871

Shift Bioscience Limited

Research and experimental development on biotechnology · Cambridge

ActiveUnited KingdomIncorporated 2017Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2025-06-30

IXBRL · 206 source facts · 24 selected values

Validation findings
XBRL valid
Reporting period
2024-07-01 to 2025-06-30
Extraction status
complete
Numeric facts
154
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_2509_10793871_20250630
Source archive
Accounts_Monthly_Data-September2025.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2024-06-30

IXBRL · 152 source facts · 20 selected values

Not assessed
legacy record
Reporting period
2023-07-01 to 2024-06-30
Extraction status
Legacy / not assessed
Numeric facts
105
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_3200_10793871_20240630
Source archive
Accounts_Monthly_Data-December2024.zip

Accounts to 2021-06-30

IXBRL · 37 source facts · 18 selected values

Not assessed
legacy record
Reporting period
2020-07-01 to 2021-06-30
Extraction status
Legacy / not assessed
Numeric facts
18
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0094_10793871_20210630
Source archive
Accounts_Monthly_Data-September2021.zip

Accounts to 2020-06-30

IXBRL · 34 source facts · 16 selected values

Not assessed
legacy record
Reporting period
2019-07-01 to 2020-06-30
Extraction status
Legacy / not assessed
Numeric facts
16
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0080_10793871_20200630
Source archive
Accounts_Monthly_Data-July2020.zip

Accounts to 2019-06-30

IXBRL · 32 source facts · 14 selected values

Not assessed
legacy record
Reporting period
2018-07-01 to 2019-06-30
Extraction status
Legacy / not assessed
Numeric facts
14
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0070_10793871_20190630
Source archive
Accounts_Monthly_Data-September2019.zip

Accounts to 2018-06-30

IXBRL · 25 source facts · 7 selected values

Not assessed
legacy record
Reporting period
2017-05-30 to 2018-06-30
Extraction status
Legacy / not assessed
Numeric facts
7
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0057_10793871_20180630
Source archive
Accounts_Monthly_Data-August2018.zip

Registered details

10793871
Status
Active
Type
Private Limited Company
Incorporated
2017-05-30
Jurisdiction
—
Registered office
SALISBURY HOUSE, STATION ROAD, CAMBRIDGE, CB1 2LA, UNITED KINGDOM

Classification

1 SIC codes
72110

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

3 matched grants
In vivo validation of safe and effective gene targets for cellular reprogramming therapiesLeadLive
Innovate UK · Collaborative R&D · 2025-04-01 – 2026-09-30
£347,693
awarded
Discovery of safe and effective gene targets for cellular reprogramming therapiesLead
Innovate UK · Collaborative R&D · 2023-07-01 – 2024-12-31
£349,993
awarded
Is the epigenetic clock accelerated by mitochondrial reprogramming via mtDNA heteroplasmy and deemed quality control?
BBSRC · Studentship · 2019-09-30 – 2024-12-10 · with 1 other participant
£0
whole project
Queen Mary University Of LondonleadShift Bioscience Limited